NC Emerge

PTCA Dilatation Catheter

Quality Outcomes: Post-dilatation has been shown to reduce complications

  • Post-dilatation reduces target vessel revascularization (TVR)7
  • NC Emerge improves compliance by 25% over the market leading NC Quantum Apex™ PTCA Dilatation Catheter*

Operational Efficiency: Help ensure total stent expansion

  • Uniform stent apposition facilitates uniform drug absorption into endothelial tissue3,4,5,6

Financial Health: Help reduce costs associated with complications8

  • Incomplete apposition may contribute to thrombosis formation & SATs, & increase risk of restenosis3,4

*Compliance Data taken from compliance charts for each reported balloon catheter

3.  Cheneau E, Leborgne L, Mintz G, et al. Predictors of Subacute Stent Thrombosis: Results of a Systematic Intravascular Ultrasound Study.  Circulation. 2003;108:43-47

4. Creel C, Lovich M, Edelman E. Arterial Paclitaxel Distribution and Deposition Circulation, 2000:86-879.

5. Hwang C, Wu D, Edelman E. Physiological Transport Force Govern Drug Distribution for Stent-Based Delivery Circulation. 2001;104:600-605

6. Leon, M. The basic “tips and tricks” for DES implantation: TCT 2003 presentation.

7. Fuji,et al. Circulation. 2004;109:1085-1088.

8. Reynolds MR, Rinaldi MJ, Pinto DS, et al. Current clinical characteristics and economic impact of subactute stent thrombosis. J Invasive Cardiol. 2002; 14:364-368.